Recruiting

Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care System

This is a retrospective observational cohort study based on secondary use of routinely collected electronic health data. The design was selected to enable population-level characterisation of treatment patterns and clinical inertia (both diagnostic and therapeutic) in the management of hypertension across diverse settings in Brazil's public primary care system (SUS).

ClinicalTrials.gov IDNCT07361276

PhaseNot Applicable

Enrollment15000

SponsorAstraZeneca

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Hypertension

About this study

Primary outcomes

Uncontrolled blood pressure (through study completion, an average of 1 year)

Eligibility information

Inclusion Criteria: * Age ≥18 years at the time of Hypertension diagnosis * Hypertension diagnosis as retrieved from registered ICD codes or CIAP Codes (primary care codes) in the EMR , OR At least two blood pressure measurements ≥140/90 mmHg during the study period. The blood measurements should be consecutive and obtained within a 30 days period. * Continuous follow-up in the same municipality for at least 6 months after index measurement. * Availability of structured EMR data including clinical encounters, diagnoses, and prescriptions Exclusion Criteria: \- Patients with incomplete data or not traceable in the registration systems

Study locations

Research Site, Florianópolis, Brazil

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.